Dr. Presant on Adjusting Clinical Trials to Value-Based Care

Video

Cary Presant, MD, FACP, FASCO, City of Hope Medical Center, discusses clinical trials and value-based care.

Cary Presant, MD, FACP, FASCO, City of Hope Medical Center, discusses how clinical trials can be changed to better align with value-based care.

Currently, there is a trend toward changing care from volume-based to value-based. Clinical trials are not value-based, what with the expenses: more testing, more evaluations, more interactions with the clinical trial team and more resources used.

To adjust for that, there are strategies that can create more value-based clinical trials. Choosing trials carefully, keeping an adequate team caring for the patient throughout the trial process, using resources efficiently, and ensuring buy-in from the entire team can help to adjust the trial system. Adjusting clinical trials currently is necessary as the reliance of value-based care becomes more acute in the future.

Related Videos
Pasi A. Jänne, MD, PhD, discusses an exploratory analysis from the FLAURA2 trial of osimertinib plus chemotherapy in treatment-naive, EGFR-mutant NSCLC.
Eric S. Christenson, MD
Samer A. Srour, MB ChB, MS
Rebecca L. Porter, MD, PhD
Deborah J. Wong, MD, PhD
Michael R. Migden, MD
Patrick I. Borgen, MD
Kari Hacker, MD, PhD, NYU Grossman School of Medicine
Janos L. Tanyi, MD, PhD, associate professor, Obstetrics and Gynecology, Hospital of the University of Pennsylvania
Reshma Lillaney Mahtani, DO